SNDX SYNDAX PHARMACEUTICALS INC Management Changes 8-K Filing 2023 - Approval of 2023 Inducement Plan Syndax Pharmaceuticals approved the 2023 Inducement Plan, which is similar to their previous plan but with some exceptions, and reserved 1,900,000 shares of common stock for issuance under the plan.Get access to all SEC 8-K filings of the SYNDAX PHARMACEUTICALS INC